Drug misuse in England and Wales: implications for family law

Beyond stereotypes

The ONS data also challenges long-standing assumptions about who is most likely to misuse drugs. While younger adults continue to report the highest levels of use, there have been increases among older age groups (e.g. aged 45-54).

This shift is significant for family law, where substance misuse may arise in cases involving older parents or carers.

Socio-economic trends further complicate the picture, with higher rates of Class A drug use reported among higher-income households, undermining assumptions that serious drug misuse is confined to economically deprived groups.

For legal practitioners, these findings reinforce the importance of avoiding assumptions based on age, income or lifestyle. Instead, objective, court-admissible drug testing remains essential to accurately assess risk and safeguarding concerns.

Which substances are driving risk

Established substances continue to dominate patterns of misuse.

• Cannabis remains the most used drug, with over 6.5% of 16-59-year-olds using it in the past year, and over a third using it daily
• Cocaine and ecstasy also remain prevalent
• Ketamine use has shown a gradual but consistent increase

However, prevalence data alone does not fully reflect the complexity encountered in family law cases. In practice, courts are increasingly dealing with misuse of controlled prescription medications, New Psychoactive Substances and poly-drug combinations, many of which are not routinely included in standard testing panels.

This is particularly relevant where substances are taken without full awareness of their composition, or where prescribed drugs are misused, complicating disclosure and risk assessment.

Implications for drug testing in family proceedings  

Reliance on standard testing panels alone no longer provides a sufficiently accurate picture of an individual’s substance use, particularly where non-standard drugs or poly-drug use are involved.

In family proceedings, a narrow testing scope may fail to identify habitual or problematic use outside standard panels.

Additionally, symptoms of drug use often overlap across different substances, meaning that symptoms alone cannot be used to determine which drugs to test for.

Accredited drug testing for legal matters

Drug misuse remains a persistent feature of life in England and Wales, with patterns of use that are broad and increasingly complex. As drug use diversifies, testing strategies must evolve accordingly.

At AlphaBiolabs, we test for the widest range of substances at our UK-based, UKAS 17025-accredited laboratory (Lab 51 extension for toxicology), including cannabis, cocaine, opiates, ecstasy/MDMA, ketamine, pregabalin, gabapentin, methadone, tramadol, benzodiazepines, hallucinogens, synthetic cannabinoids (e.g. Spice), and a wide range of emerging drugs.

To request a quote, contact our New Enquiry team on 0333 600 1300 / testing@alphabiolabs.com or complete our online quote form.